TAVR

Transcatheter aortic valve replacement (TAVR) is a key structural heart procedure that has rapidly expanded in the decade since it was first FDA cleared. TAVR has come a paradigm shift in how many aortic stenosis patients are treated, now making up more than 50% of U.S. aortic valve replacements. It is less invasive than open heart surgery and recovery times are greatly reduced. TAVR can also be used in patients who otherwise are too high risk to undergo surgery. TAVR is referred to as transcatheter aortic valve implantation (TAVI) in many placed outside of the U.S. TAVR inspired the growing areas of transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

RSS icon
Thumbnail

AI model helps clinicians predict post-TAVR infective endocarditis

To build and validate their advanced AI model, researchers explored data from nearly 78,000 TAVR hospitalizations.

quality imaging appropriateness clinical decision support CAS AUC

11% of TAVR sites deliver below-average care, suggesting a ‘meaningful performance gap’

The study’s authors developed and validated a new performance measure for TAVR care using data from more than 52,000 patients. They shared their full analysis ahead of print in Circulation.

Thumbnail

1 in 10 patients with post-TAVR infective endocarditis have a stroke, increasing risk of death by 90%

When patients with post-TAVR infective endocarditis have a stroke, their risk of in-hospital mortality and all-cause mortality after one year both skyrocket. 

How valve type and anesthesia strategy affect 1-year TAVR outcomes

Researchers in Germany explored data from more than 400 TAVR patients, sharing their findings in the Journal of the American College of Cardiology. 

Thumbnail

Risk of a permanent pacemaker after valve-in-valve TAVR is low, especially when using newer heart valves

The findings, published in the Journal of the American College of Cardiology, focused on data from the VIVID registry.

SCAI 2021: Medtronic pleased with 30-day data on Evolut TAVR systems

Researchers presented 30-day data at the SCAI 2021 Scientific Sessions, highlighting the "excellent" outcomes and the importance of constantly working to improve patient care. 

Thumbnail

SCAI 2021: 98% of new TAVR programs developed in metropolitan areas

Researchers tracked 554 TAVR programs that opened from 2012 to 2018, sharing their findings at the SCAI 2021 Scientific Sessions.

Thumbnail

Surgical risk scores may not be needed when considering TAVR

Recent TAVR research suggests clinicians should focus on other key factors such as the patient's age and life expectancy. 

Displaying 353 - 360 of 416

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Design by Adaptive Theme
Trimed Popup
Trimed Popup